Marcio H Malogolowkin

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, Los Angeles, CA 90027, USA
    J Clin Oncol 24:2879-84. 2006
  2. ncbi Treatment of hepatoblastoma: the North American cooperative group experience
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA
    Front Biosci (Elite Ed) 4:1717-23. 2012
  3. ncbi Redefining the role of doxorubicin for the treatment of children with hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, 4650 Sunset Blvd, MS 54, Los Angeles, CA 90027, USA
    J Clin Oncol 26:2379-83. 2008
  4. ncbi Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group
    Marcio H Malogolowkin
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Clin Oncol 29:3301-6. 2011
  5. ncbi Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 59:493-8. 2012
  6. ncbi Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience
    Catherine E Madigan
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Cancer 110:2061-6. 2007
  7. ncbi Pleuropulmonary blastoma: a single-institution experience
    Rajkumar Venkatramani
    Division of Hematology Oncology, Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Pediatr Hematol Oncol 34:e182-5. 2012
  8. ncbi Current and future management strategies for relapsed or progressive hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Childrens Hospital Los Angeles, CA, USA
    Paediatr Drugs 14:221-32. 2012
  9. ncbi Treatment of infantile choriocarcinoma of the liver
    Janet M Yoon
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 49:99-102. 2007
  10. ncbi Gorham's disease and diffuse lymphangiomatosis in children and adolescents
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 56:667-70. 2011

Detail Information

Publications15

  1. ncbi Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, Los Angeles, CA 90027, USA
    J Clin Oncol 24:2879-84. 2006
    ..The P9645 study was designed to compare the risk of treatment failure for patients with stage III/IV hepatoblastoma randomized to either C5V or CC...
  2. ncbi Treatment of hepatoblastoma: the North American cooperative group experience
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA
    Front Biosci (Elite Ed) 4:1717-23. 2012
    ..In North America, children with malignant liver tumors have been treated in a cooperative group study since early 1970s. This manuscript describes the results of these studies...
  3. ncbi Redefining the role of doxorubicin for the treatment of children with hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, 4650 Sunset Blvd, MS 54, Los Angeles, CA 90027, USA
    J Clin Oncol 26:2379-83. 2008
    ..However, international cooperative groups still favor the CD combination. We therefore decided to revisit the role of doxorubicin for the treatment of HB...
  4. ncbi Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group
    Marcio H Malogolowkin
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Clin Oncol 29:3301-6. 2011
    ..We prospectively studied the safety and efficacy of reducing therapy in all children with stage I PFH enrolled onto two consecutive studies...
  5. ncbi Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 59:493-8. 2012
    ..We evaluated whether tumor necrosis following neo-adjuvant chemotherapy is prognostic for survival in hepatoblastoma (HB)...
  6. ncbi Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience
    Catherine E Madigan
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Cancer 110:2061-6. 2007
    ..Extracranial malignant rhabdoid tumor (MRT) is a rare, aggressive, pediatric malignancy with a historically poor outcome. Recent efforts to intensify treatment for MRT have resulted in isolated reports of long-term survival...
  7. ncbi Pleuropulmonary blastoma: a single-institution experience
    Rajkumar Venkatramani
    Division of Hematology Oncology, Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Pediatr Hematol Oncol 34:e182-5. 2012
    ..A high index of suspicion for PPB must be maintained in all patients diagnosed with intrathoracic sarcoma in early childhood. Gross total resection is necessary for cure, and selected patients do not require radiation therapy...
  8. ncbi Current and future management strategies for relapsed or progressive hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Childrens Hospital Los Angeles, CA, USA
    Paediatr Drugs 14:221-32. 2012
    ..Gene-directed therapy and immunotherapy have shown promising results in the preclinical setting, and should be investigated as future treatment options for advanced hepatoblastoma...
  9. ncbi Treatment of infantile choriocarcinoma of the liver
    Janet M Yoon
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 49:99-102. 2007
    ..She is currently in continuous remission 24 months from diagnosis...
  10. ncbi Gorham's disease and diffuse lymphangiomatosis in children and adolescents
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 56:667-70. 2011
    ..Soft tissue lymphangioma was present in seven and six children had splenic involvement. Disease stabilization and improvement was observed on treatment with interferon alpha-2b and bisphosphonate therapy...
  11. ncbi Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma
    Rebecka L Meyers
    Division of Pediatric Surgery, Primary Children s Medical Center, University of Utah, Salt Lake City, UT 84113, USA
    J Pediatr Surg 42:2050-6. 2007
    ..In this study, we aimed to determine the long-term outcome of patients with hepatoblastoma who have a surgical resection of pulmonary metastatic lesions...
  12. ncbi Fibrolamellar hepatocellular carcinoma in children and adolescents
    Howard M Katzenstein
    Department of Pediatrics, Children s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA
    Cancer 97:2006-12. 2003
    ....
  13. ncbi Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study
    Howard M Katzenstein
    Department of Pediatrics and Surgery, Northwestern University and Children s Memorial Hospital, Chicago, IL, USA
    J Clin Oncol 20:2789-97. 2002
    ....
  14. ncbi Predictive value of staging systems in hepatoblastoma
    Rebecka L Meyers
    J Clin Oncol 25:737; author reply 737-8. 2007
  15. ncbi Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study
    Neyssa Marina
    Stanford University Medical Center, Stanford, CA 94304 1812, USA
    J Clin Oncol 24:2544-8. 2006
    ..To investigate prognostic factors for pediatric extragonadal malignant germ cell tumors (PEMGCT)...